Deutsche Bank Ag\ Ani Pharmaceuticals Inc Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 232,328 shares of ANIP stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
232,328
Previous 232,600
0.12%
Holding current value
$13.7 Million
Previous $13.9 Million
7.44%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding ANIP
# of Institutions
212Shares Held
18.9MCall Options Held
11.7KPut Options Held
7K-
Black Rock Inc. New York, NY2.66MShares$157 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$77.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$59.1 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$43.4 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$41.2 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.03B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...